标题
The bone-marrow niche in MDS and MGUS: implications for AML and MM
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 15, Issue 4, Pages 219-233
出版商
Springer Nature
发表日期
2018-01-09
DOI
10.1038/nrclinonc.2017.197
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mechanisms of Resistance to FLT3 Inhibitors and the Role of the Bone Marrow Microenvironment
- (2017) Gabriel Ghiaur et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells
- (2017) A Ray et al. LEUKEMIA
- Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
- (2017) S V Glavey et al. LEUKEMIA
- Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
- (2017) H Ludwig et al. LEUKEMIA
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors
- (2017) Anna Mies et al. SEMINARS IN HEMATOLOGY
- The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
- (2016) A. A. Basiorka et al. BLOOD
- Chimeric Antigen Receptor (CAR) therapy for multiple myeloma
- (2016) Djordje Atanackovic et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia
- (2016) Jeevisha Bajaj et al. CANCER CELL
- Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model
- (2016) Antonio Sacco et al. CANCER RESEARCH
- Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
- (2016) Noemi A. Zambetti et al. Cell Stem Cell
- Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications
- (2016) Anna Mies et al. CURRENT PHARMACEUTICAL DESIGN
- Oxidative stress and hypoxia in normal and leukemic stem cells
- (2016) Ugo Testa et al. EXPERIMENTAL HEMATOLOGY
- Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice
- (2016) Junping Xin et al. HAEMATOLOGICA
- T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
- (2016) Claudia Zelle-Rieser et al. Journal of Hematology & Oncology
- Targeting vasculogenesis to prevent progression in multiple myeloma
- (2016) M Moschetta et al. LEUKEMIA
- Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice
- (2016) Rituparna Das et al. NATURE MEDICINE
- Ipilimumab for Patients with Relapse after Allogeneic Transplantation
- (2016) Matthew S. Davids et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System
- (2016) Vivien J. Coulson-Thomas et al. Ocular Surface
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial
- (2016) J J Shah et al. Blood Cancer Journal
- Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network
- (2016) Bing Z. Carter et al. Oncotarget
- Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice
- (2016) Junping Xin et al. HAEMATOLOGICA
- PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
- (2016) T. Jelinek et al. OncoImmunology
- Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
- (2016) David A. Sallman et al. Frontiers in Oncology
- The immunomodulatory function of mesenchymal stem cells: mode of action and pathways
- (2015) Antonio Uccelli et al. Annals of the New York Academy of Sciences
- Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome
- (2015) S. R. Balderman et al. BLOOD
- The hematopoietic stem cell niche in homeostasis and disease
- (2015) L. M. Calvi et al. BLOOD
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
- (2015) D. P. Steensma et al. BLOOD
- Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
- (2015) P. Maiso et al. CANCER RESEARCH
- Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities
- (2015) Koen Schepers et al. Cell Stem Cell
- Immunotherapy for multiple myeloma: Current status and future directions
- (2015) Ayed O. Ayed et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
- (2015) Chan Yoon Cheah et al. CURRENT OPINION IN ONCOLOGY
- Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
- (2015) Tuomas Laukka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study
- (2015) Lene Sofie Granfeldt Østgård et al. JOURNAL OF CLINICAL ONCOLOGY
- FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice
- (2015) A Kode et al. LEUKEMIA
- Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins
- (2015) Valeria Magarotto et al. LEUKEMIA & LYMPHOMA
- Bone marrow niche in the myelodysplastic syndromes
- (2015) Christopher R. Cogle et al. LEUKEMIA RESEARCH
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma
- (2015) Kimberly A. Noonan et al. Science Translational Medicine
- A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease
- (2015) Frits van Rhee et al. Oncotarget
- CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
- (2015) Aldo M. Roccaro et al. Cell Reports
- Endothelial Progenitor Cell Dysfunction in Myelodysplastic Syndromes: Possible Contribution of a Defective Vascular Niche to Myelodysplasia
- (2015) Luciana Teofili et al. NEOPLASIA
- Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
- (2015) Athalia R Pyzer et al. Human Vaccines & Immunotherapeutics
- A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome
- (2014) Guillermo Garcia-Manero et al. AMERICAN JOURNAL OF HEMATOLOGY
- A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
- (2014) Robert Z. Orlowski et al. AMERICAN JOURNAL OF HEMATOLOGY
- The osteoblastic niche in the context of multiple myeloma
- (2014) Denise Toscani et al. Annals of the New York Academy of Sciences
- How I treat smoldering multiple myeloma
- (2014) I. M. Ghobrial et al. BLOOD
- Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model
- (2014) M. R. Reagan et al. BLOOD
- Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
- (2014) J. Wang et al. BLOOD
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- (2014) R. C. Lindsley et al. BLOOD
- Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF- B mediates chemoresistance
- (2014) R. Jacamo et al. BLOOD
- A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
- (2014) Swaminathan P. Iyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin
- (2014) Soraya Carrancio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Contributions of the Host Microenvironment to Cancer-Induced Bone Disease
- (2014) Sam W.Z. Olechnowicz et al. CANCER RESEARCH
- Myelodysplastic Cells in Patients Reprogram Mesenchymal Stromal Cells to Establish a Transplantable Stem Cell Niche Disease Unit
- (2014) Hind Medyouf et al. Cell Stem Cell
- Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease
- (2014) Adriana Zingone et al. CYTOKINE
- Targeting the bone marrow microenvironment in multiple myeloma
- (2014) Yawara Kawano et al. IMMUNOLOGICAL REVIEWS
- CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes
- (2014) Shiho Abe-Suzuki et al. LABORATORY INVESTIGATION
- Myelodysplasia is in the niche: novel concepts and emerging therapies
- (2014) E Bulycheva et al. LEUKEMIA
- Hypoxia Promotes Dissemination and Colonization in New Bone Marrow Niches in Waldenström Macroglobulinemia
- (2014) Barbara Muz et al. MOLECULAR CANCER RESEARCH
- Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
- (2014) Aruna Kode et al. NATURE
- An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
- (2014) Michael Dussiot et al. NATURE MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineered nanomedicine for myeloma and bone microenvironment targeting
- (2014) A. Swami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy
- (2014) Aldo M. Roccaro et al. Cell Reports
- Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
- (2013) G. T. Gorgun et al. BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients
- (2013) J. Rosenblatt et al. CLINICAL CANCER RESEARCH
- Murine xenogeneic models of myelodysplastic syndrome: An essential role for stroma cells
- (2013) Xiang Li et al. EXPERIMENTAL HEMATOLOGY
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Induction of myelodysplasia by myeloid-derived suppressor cells
- (2013) Xianghong Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma
- (2013) D Atanackovic et al. LEUKEMIA
- CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
- (2013) Y-T Tai et al. LEUKEMIA
- Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells
- (2013) S Geyh et al. LEUKEMIA
- Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy
- (2013) Esther N. Oliva et al. LEUKEMIA & LYMPHOMA
- Dynamic Chemotherapy-Induced Upregulation of CXCR4 Expression: A Mechanism of Therapeutic Resistance in Pediatric AML
- (2013) E. A. R. Sison et al. MOLECULAR CANCER RESEARCH
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
- (2013) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Different Immunoregulatory Functions on Dendritic Cells between Mesenchymal Stem Cells Derived from Bone Marrow of Patients with Low-Risk or High-Risk Myelodysplastic Syndromes
- (2013) Zhenling Wang et al. PLoS One
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
- (2012) A. K. Azab et al. BLOOD
- Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion
- (2012) C. Tripodo et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH
- (2012) Fábio Morato de Oliveira et al. EXPERIMENTAL HEMATOLOGY
- Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
- (2012) C. Santamaria et al. HAEMATOLOGICA
- Elotuzumab in Combination With Lenalidomide and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
- (2012) Sagar Lonial et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
- (2012) Eunice S Wang et al. Journal of Hematology & Oncology
- SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status
- (2012) L López-Corral et al. LEUKEMIA
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Clonal Architecture of Secondary Acute Myeloid Leukemia
- (2012) Matthew J. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts
- (2011) O. Blau et al. BLOOD
- T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone
- (2011) Suzanne M. Vercauteren et al. BRITISH JOURNAL OF HAEMATOLOGY
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects
- (2011) M. R. Reagan et al. CLINICAL CANCER RESEARCH
- Focal adhesion protein abnormalities in myelodysplastic mesenchymal stromal cells
- (2011) Carmen Mariana Aanei et al. EXPERIMENTAL CELL RESEARCH
- The hematopoietic stem cell niche
- (2011) Dongsu Park Frontiers in Bioscience-Landmark
- Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System
- (2011) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
- (2011) Jacalyn Rosenblatt et al. JOURNAL OF IMMUNOTHERAPY
- Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
- (2011) Gareth J Morgan et al. LANCET ONCOLOGY
- Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study
- (2011) Giovanni D'arena et al. LEUKEMIA & LYMPHOMA
- SDF-1/CXCR4 axis in myelodysplastic syndromes: Correlation with angiogenesis and apoptosis
- (2011) Yizhuo Zhang et al. LEUKEMIA RESEARCH
- Intrinsic Growth Deficiencies of Mesenchymal Stromal Cells in Myelodysplastic Syndromes
- (2011) Carmen Mariana Aanei et al. STEM CELLS AND DEVELOPMENT
- Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management
- (2010) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug
- (2010) J. Hu et al. BLOOD
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
- (2010) D. M. Benson et al. BLOOD
- A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
- (2010) K. Noonan et al. BLOOD
- Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept
- (2010) Bart L. Scott et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study
- (2010) Bart L. Scott et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
- (2010) X. Feng et al. HAEMATOLOGICA
- Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype
- (2010) S. Ghannam et al. JOURNAL OF IMMUNOLOGY
- Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells
- (2010) S Colla et al. LEUKEMIA
- The lower risk MDS patient at risk of rapid progression
- (2010) Moshe Mittelman et al. LEUKEMIA RESEARCH
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
- (2010) Marc H. G. P. Raaijmakers et al. NATURE
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
- (2010) Soufiane Ghannam et al. Stem Cell Research & Therapy
- An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma
- (2009) Ravi Vij et al. AMERICAN JOURNAL OF HEMATOLOGY
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- CD4+CD25+FoxP3+regulatory T cells are increased whilst CD3+CD4−CD8−αβTCR+Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden
- (2009) Sylvia Feyler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
- (2009) Dharminder Chauhan et al. CANCER CELL
- Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease
- (2009) Katia Todoerti et al. EXPERIMENTAL HEMATOLOGY
- Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
- (2009) M Garayoa et al. LEUKEMIA
- Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma
- (2009) M Roussou et al. LEUKEMIA
- Stem-cell ecology and stem cells in motion
- (2008) T. Papayannopoulou et al. BLOOD
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow
- (2008) Feng-Chun Yang et al. CELL
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
- The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
- (2008) Ling Lu et al. MICROVASCULAR RESEARCH
- An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome
- (2008) Benjamin L Ebert et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search